整合增强暗-亮-暗征与MRI特征诊断直肠癌淋巴结转移
这项两中心回顾性研究开发并验证了整合增强T1WI暗-亮-暗征、肿瘤特征和ESGAR标准的增强MRI模型预测直肠癌病理淋巴结转移,并与非增强模型、单纯ESGAR标准及单纯短轴直径比较。增强模型在训练集和外部测试集的AUC分别为0.89和0.83,优于其他方法(均P<.001),在短轴直径<5 mm或病理T2期亚组中亦优于ESGAR特征。
要点
- 增强MRI模型整合暗-亮-暗征、肿瘤特征和ESGAR标准,训练集AUC 0.89、外部测试集AUC 0.83。
- 增强模型优于单纯短轴直径、单纯ESGAR标准和非增强模型(均P<.001)。
- 短轴直径<5 mm亚组中增强模型训练集AUC 0.88、外部测试集AUC 0.90,优于ESGAR特征。
核心结论
- 整合肿瘤特征尤其是暗-亮-暗征与ESGAR状态可改善术前淋巴结转移诊断,在淋巴结小于5 mm或病理T2期患者中尤为明显。
研究设计与样本
- 两中心回顾性研究,训练集922例(中心1,2016年1月至2024年12月),外部测试集149例(中心2,2016年1月至2019年1月),以病理淋巴结转移为参考标准,采用逻辑回归开发增强与非增强MRI模型。
关键影像表现/征象
- 暗-亮-暗征定义为增强T1WI上内层低信号肿瘤(暗)、中层高信号环(亮)和外层低信号固有肌层(暗)。
- 增强模型训练集AUC 0.89(95%CI:0.86,0.90),外部测试集AUC 0.83(95%CI:0.76,0.90)。
诊断标准与关键数值
- 增强模型训练集AUC 0.89(95%CI:0.86,0.90)、外部测试集AUC 0.83(95%CI:0.76,0.90),优于单纯短轴直径、单纯ESGAR标准和非增强模型(均P<.001)。
- 短轴直径<5 mm亚组:增强模型训练集AUC 0.88(95%CI:0.85,0.92)、外部测试集AUC 0.90(95%CI:0.80,0.96),优于ESGAR特征。
- 病理T2期亚组:增强模型训练集AUC 0.89(95%CI:0.84,0.93)、外部测试集AUC 0.91(95%CI:0.80,1.00),优于ESGAR特征。
临床应用与阅片要点
- 增强T1WI上可关注暗-亮-暗征:内层低信号肿瘤、中层高信号环和外层低信号固有肌层。
- 对短轴直径<5 mm或病理T2期的直肠癌患者,增强模型较ESGAR特征有更高的AUC。
局限性
- 原文未报告本研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Accurately diagnosing lymph node metastasis (LNM) in patients with rectal cancer preoperatively can guide treatment but remains challenging. Purpose To develop and validate an enhanced MRI model incorporating the so-called dark-light-dark sign on contrast-enhanced T1-weighted MRI scans, tumor features, and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) criteria for predicting pathologic LNM (pLNM) and to compare its efficacy to a nonenhanced MRI model without the dark-light-dark sign, ESGAR size and lymph node features alone, and lymph node short-axis diameter alone. Materials and Methods This two-center retrospective study included patients with rectal cancer who underwent primary surgery (center 1, January 2016 to December 2024; center 2, January 2016 to January 2019). The dark-light-dark sign was defined as the presence of an inner hypointense tumor (dark), an intermediate hyperintense rim (light), and an outer hypointense muscularis propria (dark). Enhanced and plain scan models were developed by using logistic regression. Diagnostic performance was compared with the receiver operating characteristic curve. Results The training set consisted of 922 patients, 354 of whom were pLNM positive (mean age, 60 years ± 12 [SD]; 211 men) and 568 of whom were pLNM negative (mean age, 61 years ± 11; 347 men); the external test set consisted of 149 patients, 73 of whom were pLNM positive (mean age, 61 years ± 12; 51 men) and 76 of whom were pLNM negative (mean age, 62 years ± 11; 45 men). The enhanced model yielded areas under the receiver operating characteristic curve (AUCs) of 0.89 (95% CI: 0.86, 0.90) and 0.83 (95% CI: 0.76, 0.90) in the training and external test sets, respectively, outperforming lymph node short-axis diameter alone, ESGAR alone, and the nonenhanced model (all P < .001). The enhanced model outperformed ESGAR features in subgroups with lymph node short-axis diameters of less than 5 mm (training set: AUC, 0.88 [95% CI: 0.85, 0.92]; external test set: AUC, 0.90 [95% CI: 0.80, 0.96]) and pathologic T2 stage (training set: AUC, 0.89 [95% CI: 0.84, 0.93]; external test set: AUC, 0.91 [95% CI: 0.80, 1.00]). Conclusion Integrating tumor characteristics-especially the dark-light-dark sign-with ESGAR status improved preoperative LNM diagnosis, particularly in patients with lymph nodes smaller than 5 mm or who had stage T2 tumors. © The Author(s). Published by the Radiological Society of North America under a CC BY 4.0 license. Supplemental material is available for this article.
引用
- Yan XY, Wang XC, Wu JQ, et al. Integrating Contrast-Enhanced Dark-Light-Dark Sign and MRI Features for Rectal Cancer Lymph Node Diagnosis. Radiology. 2025. PMID: 41432559. doi:10.1148/radiol.251556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。